...
首页> 外文期刊>Toxicology and Applied Pharmacology >MRP2 and the handling of mercuric ions in rats exposed acutely to inorganic and organic species of mercury.
【24h】

MRP2 and the handling of mercuric ions in rats exposed acutely to inorganic and organic species of mercury.

机译:MRP2和大鼠中汞离子的处理都暴露于无机和有机汞物种。

获取原文
获取原文并翻译 | 示例
           

摘要

Mercuric ions accumulate preferentially in renal tubular epithelial cells and bond with intracellular thiols. Certain metal-complexing agents have been shown to promote extraction of mercuric ions via the multidrug resistance-associated protein 2 (MRP2). Following exposure to a non-toxic dose of inorganic mercury (Hg(2)+), in the absence of complexing agents, tubular cells are capable of exporting a small fraction of intracellular Hg(2)+ through one or more undetermined mechanisms. We hypothesize that MRP2 plays a role in this export. To test this hypothesis, Wistar (control) and TR(-) rats were injected intravenously with a non-nephrotoxic dose of HgCl (0.5 mumol/kg) or CHHgCl (5 mg/kg), containing [(2)(3)Hg], in the presence or absence of cysteine (Cys; 1.25 mumol/kg or 12.5mg/kg, respectively). Animals were sacrificed 24 h after exposure to mercury and the content of [(2)(3)Hg] in blood, kidneys, liver, urine and feces was determined. In addition, uptake of Cys-S-conjugates of Hg(2)+ and methylmercury (CHHg+) was measured in inside-out membrane vesicles prepared from either control Sf9 cells or Sf9 cells transfected with human MRP2. The amount of mercury in the total renal mass and liver was significantly greater in TR rats than in controls. In contrast, the amount of mercury in urine and feces was significantly lower in TR rats than in controls. Data from membrane vesicles indicate that Cys-S-conjugates of Hg(2)+ and CHHg+ are transportable substrates of MRP2. Collectively, these data indicate that MRP2 plays a role in the physiological handling and elimination of mercuric ions from the kidney.
机译:汞离子优先在肾小管上皮细胞中积累,并与细胞内硫醇键合。已显示某些金属络合剂可通过多药耐药相关蛋白2(MRP2)促进汞离子的提取。在暴露于无毒剂量的无机汞(Hg(2)+)之后,在没有络合剂的情况下,肾小管细胞能够通过一种或多种不确定的机制输出小部分细胞内Hg(2)+。我们假设MRP2在此导出中起作用。为了验证该假设,向Wistar(对照)和TR(-)大鼠静脉注射非肾毒性剂量的HgCl(0.5 mumol / kg)或CHHgCl(5 mg / kg),其中含有[(2)(3)Hg ],是否存在半胱氨酸(Cys;分别为1.25μmol/ kg或12.5mg / kg)。暴露于汞后24小时处死动物,并测定其在血液,肾脏,肝脏,尿液和粪便中的[(2)(3)Hg]含量。另外,在由对照Sf9细胞或用人MRP2转染的Sf9细胞制备的由内而外的膜囊泡中测量了Hg(2)+和甲基汞(CHHg +)的Cys-S偶联物的摄取。 TR大鼠的总肾脏和肝脏中的汞含量明显高于对照组。相反,TR大鼠的尿液和粪便中的汞含量明显低于对照组。来自膜囊泡的数据表明,Hg(2)+和CHHg +的Cys-S-共轭物是MRP2的可运输底物。总的来说,这些数据表明,MRP2在生理处理和从肾脏消除汞离子中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号